2Ruping M J,Heinz W J,Kindo A J. Forty-one recent cases of invasive zygomycosis from a global clinical registry[J].Journal of Antimicrobial Chemotherapy,2010,(02):296-302.
3Roden M M,Zaoutis T E,Buchanan W L. Epidemiology and outcome of zygomycosis:A review of 929 reported cases[J].Clinical Infectious Diseases,2005,(05):634-653.
5Kauffman C A,Malani A N. Zygomycosis:an emerging fungal infection with new options for management[J].Current Infectious Disease Reports,2007,(06):435-440.
7Arredondo-Garcia1 J L,Amabile-Cuevas C F,RedMic2 Study Group. Susceptibility of Mexican isolates of yeasts and moulds to amphotericin B and triazole antifungals[J].Infect Dev Ctries,2009,(05):398-401.
二级参考文献1
1Greenberg RN,Nullane K,,van Burik JA,et al.Posaconazole as salrage therapy for zygomycosis.Antimicrob Agents Chemother,2006,50:128-133.
